A phase I, open-label, study of GSK2879552, a lysine-specific demethylase 1 (LSD1) inhibitor, in patients with relapsed/refractory small cell lung carcinoma (SCLC) [PDF]
Víctor Moreno+8 more
openalex +1 more source
Correction: LSD1 is required for euchromatic origin firing and replication timing. [PDF]
Wang Y+9 more
europepmc +1 more source
Regulation of Lipogenic Gene Expression by Lysine-specific Histone Demethylase-1 (LSD1)
Arian Abdulla+7 more
openalex +1 more source
GPX3 Overexpression Ameliorates Cardiac Injury Post Myocardial Infarction Through Activating LSD1/Hif1α Axis. [PDF]
Jiang QQ+14 more
europepmc +1 more source
RETRACTED: Long Noncoding RNA LINC00673 Is Activated by SP1 and Exerts Oncogenic Properties by Interacting with LSD1 and EZH2 in Gastric Cancer [PDF]
Mingde Huang+7 more
openalex +1 more source
In vitro functional validation of anti-CD19 chimeric antigen receptor T cells expressing lysine-specific demethylase 1 short hairpin RNA for the treatment of diffuse large B cell lymphoma. [PDF]
Guo Z+6 more
europepmc +1 more source
LincRNAFEZF1-AS1 represses p21 expression to promote gastric cancer proliferation through LSD1-Mediated H3K4me2 demethylation [PDF]
Yan-wen Liu+8 more
openalex +1 more source
Discovery of novel dual-target inhibitors of LSD1/EGFR for non-small cell lung cancer therapy. [PDF]
Wei Y+6 more
europepmc +1 more source
Altering the Course of Small Cell Lung Cancer: Targeting Cancer Stem Cells via LSD1 Inhibition
C. Allison Stewart, Lauren A. Byers
openalex +1 more source
Coordinated neuron-specific splicing events restrict nucleosome engagement of the LSD1 histone demethylase complex. [PDF]
Porter RS+15 more
europepmc +1 more source